10 – 12 October, 2018, Pacifico Yokohama, Yokohama, Japan
Selexis will be participating in the partnering program.
More information 

5-7 November, 2018, Bella Center Copenhagen, Denmark Copenhagen Denmark
Selexis will be participating in the partnering program.
More information

JAACT 2018
5-8 November, 2018, Tsukuba International Congress Center Tsukuba Japan
More information

PEGS Europe 2018
12-16 November, 2018, Liston Congress Center, Liston,Portugal Lisbon Portugal
Selexis will present, sponsor and exhibit at the conference.
Selexis’ CEO, Igor Fisch, PhD, will be presenting on Wednesday, November 14 at 10:05 AM as part of the Optimising Expression Platforms tract.
Selexis’ SUREscan and SUREsignature: Technologies for the Assessment of Cell Line Integrity and Clonality
Selexis’ SUREscan utilizes NGS technologies and proprietary bioinformatics to comprehensively assess the genomic architecture of Selexis-generated cell lines. SUREsignature is a unique, genome-wide collection of genetic markers that establishes cell line clonality to a probability significance not previously achievable and determines cell line-specific barcodes for better master cell bank quality control. These technologies minimize risk and accelerate biologics development by allowing for optimal clone selection and monitoring.
More information